triplet therapy for certain patients with metastatic crc shows promise, but more research is needed
Published 4 years ago • 56 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
7:02
triplet regimens in braf-mutant metastatic crc
-
2:07
triplet regimen improves responses in braf v600e metastatic crc
-
30:46
metastatic melanoma - doublet vs triplet therapy
-
35:27
expert perspectives: optimizing late-line therapy for patients with metastatic colorectal cancer
-
6:32
panitumumab triplet therapy in colorectal cancer
-
20:52
what is the optimal therapy for braf mutant metastatic colorectal cancer?
-
13:11
treatment sequencing in metastatic colorectal cancer
-
6:06
colorectal cancer debate: first line braf v600e - targeted triplet
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
36:11
first-line drug therapy selection strategy for metastatic colorectal cancer treatment
-
4:57
case 2: maintenance therapy in mcrc
-
5:54
initial systemic therapy for metastatic colorectal cancer
-
15:55
should msi be determined in all patients with stage ii and iii colon cancer patients?
-
15:12
initial management of metastatic crc in 2019
-
9:25
debate: msi high colon cancer - immunotherapy
-
5:52
third-line therapy for metastatic colon cancer
-
8:04
first- and second-line treatment for mcrc in specific populations
-
29:45
keynote lecture 4: the braf pathway in crc?
-
5:55
options for third-line therapy in metastatic crc